ON-DEMAND WEBINAR
Unlocking innovation in cardiac drug discovery
Automation of 3D organoid culture powered by machine learning and advanced image analysis
Cardiovascular disease (CVD) remains a significant global health concern, accounting for 32% of all mortalities. The absence of reliable and representative human heart in vitro models poses a significant challenge in drug discovery, impeding the development of effective treatments.
In this presentation from SLAS EU 2025, Dr. Florian Fuchs, CTO of HeartBeat.Bio, and Dr. Oksana Sirenko of Molecular Devices discuss a fully automated high-throughput platform for culturing induced pluripotent stem cells (iPSC) and differentiating them into 3D self-organizing cardiac organoids (cardioids).
Heading
Register to watch the on-demand webinar now
Product family
CX.ai
Product primary application
CellXpress.ai Automated Cell Culture System; Organoids
cmp
701Rn00000iwoKxIAI
Title
Unlocking innovation in cardiac drug discovery
Resource URL
Resource Image URL
